What Does an Imperial Hegemon Mean for Research Ethics?
By Jonathan D. Moreno,
Hastings Center Bioethics Forum
| 02. 09. 2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica. For pretty much everyone else this claim was interesting when identified but paled in comparison to an ongoing global pandemic. During my first few presentations early in 2024 in places like Krakow, Singapore, and Vienna, audiences of academics acknowledged that this was a thing but maybe not an immediate thing.
It turned out to be a pretty immediate thing.
I think it’s fair to say that neither the experts nor the more casual observers (nor this writer), appreciated the Formula One-level acceleration that the still-young year 2026 has already witnessed. If Canadian Prime Minister Mark Carney’s remarks at the World Economic Forum weren’t quite at the historic scale of Winston Churchill’s “iron curtain” speech, they at least set down a marker that the Trump administration had turned U.S. foreign policy in the direction of an “imperial hegemon,” political science jargon...
Related Articles
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...